Valentina Puentmann: Clinical Trials

1 trial sponsored by Valentina Puentmann, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Valentina Puentmann: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19
Prednisolone, Losartan - COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle
Phase 3Active not recruitingValentina Puentmann2792022-12-122025-12-09

Conditions studied

Microvascular Angina (1)  ·  Myocarditis (1)  ·  Pericarditis (1)  ·  Post-Acute COVID-19 Syndrome (1)  ·  Vascular Remodeling (1)  ·  Ventricular Dysfunction, Left (1)  ·  Ventricular Remodeling (1)

Interventions

Losartan (1)  ·  Prednisolone (1)

Countries

Austria (1)  ·  Germany (1)

Top investigators

Eike Nagel, MD, PhD (1)  ·  Valentina Puntmann, MD, PhD (1)

Results publications

PMID 42533000